In this PharmTech video feature, I highlight the week’s industry news in an easy-to-consume format. New roundups drop every ...

Marcio Temtem, vice president, Strategic Business Management, Hovione, addresses molecule complexity, speed, and ...

Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.

FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...

Regarding the industry's talent pipeline, Dr. de Miguel highlights the importance of education programs in the fields of science, technology, engineering, and mathematics (STEM) in building the ...

Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...

ACG’s Shirwal site is the first pharmaceutical packaging site in the WEF Lighthouse Network, using digital tools to cut ...

In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...

The companies’ “Change the Target. Change What’s Possible” targets the potential of Factor XIa inhibition in the development ...

Priority Review was granted by FDA for the first line metastatic TNBC treatment. Datroway significantly improved survival ...

FDA Commissioner Marty Makary, M.D., M.P.H., characterized the program as a “bold step” to bring manufacturing back to the US and make the domestic sector more resilient and competitive. This program ...

Nine recommendations for extending therapeutic indications reflect ongoing lifecycle management and utility expansion of ...